1. Sign up to Bitpanda
Sign up to create your free Bitpanda account.
Bitpanda makes it easy for you to invest in Genmab from as little as €1. Invest 24/7 with zero commissions and tight spreads.
* Past performance is no indication of future results. Bitpanda Stocks are contracts replicating an underlying stock or ETF.
* Past performance is no indication of future results. Bitpanda Stocks are contracts replicating an underlying stock or ETF.
Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukeamia. The company was founded by Donald Lee Drakeman, Florian Schonharting and Jan G. J. van de Winkel in 1999 and is headquartered in Copenhagen, Denmark.
Sign up to create your free Bitpanda account.
Verify your identity with one of our trusted verification partners.
Deposit your funds securely through our supported options.
You’re all set! Start buying Genmab and over 3,000 other digital assets.
To view older versions of these documents, click here
This content is provided for marketing communication purposes and aims to offer non-binding information only. It does not constitute advice, a recommendation or an invitation to conclude a transaction. “Bitpanda Stocks” are brought to you in cooperation with Bitpanda Financial Services GmbH. Bitpanda Stocks are not stocks but derivative agreements that allow you to participate in the price movements of certain underlying financial instruments (such as stocks or Exhange Traded Funds). Bitpanda Stocks cannot be traded on stock exchanges or other trading venues, but can be resold to Bitpanda at any time under the applicable terms set out in the Bitpanda Financial Services Terms and Conditions and the derivative agreement for A-Token. For further details about Bitpanda GmbH as issuer and the relevant risks associated with the product, consult the prospectus available in German (audited version) and English at bitpanda.com. Please note that this product is only subject to this prospectus in Austria. Risk warning: Investing in digital assets carries risk. The value of digital assets is subject to volatility. You could sustain a loss of some or all of your investment. Past performance is not indicative of future performance.